Livedoid vasculopathy
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Livedoid vasculopathy | |
|---|---|
| File:Livedoid Vasculopathy.jpg | |
| Synonyms | Livedoid vasculitis, Atrophie blanche |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Painful ulcers, purpura, livedo reticularis |
| Complications | Chronic pain, infection, scarring |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Vascular disease, coagulation disorders |
| Risks | Thrombophilia, autoimmune disorders |
| Diagnosis | Clinical diagnosis, skin biopsy |
| Differential diagnosis | Vasculitis, chronic venous insufficiency, cryoglobulinemia |
| Prevention | N/A |
| Treatment | Anticoagulants, anti-inflammatory medications, pain management |
| Medication | Aspirin, pentoxifylline, corticosteroids |
| Prognosis | Variable, often chronic |
| Frequency | Rare |
| Deaths | N/A |
Livedoid vasculopathy (LV), also known as livedoid vasculitis or atrophie blanche, is a rare, chronic vascular disorder characterized by recurrent painful ulcerations and purpuric skin lesions, primarily affecting the lower extremities. It is considered a form of thrombotic vasculopathy, leading to occlusion of small dermal blood vessels and tissue necrosis.
Pathophysiology[edit]
Livedoid vasculopathy is a non-inflammatory thrombotic vasculopathy involving occlusion of small dermal blood vessels. The underlying mechanisms include:
- Hypercoagulability – Increased clotting tendency leading to microvascular thrombosis.
- Endothelial dysfunction – Damage to small blood vessels in the dermis.
- Impaired fibrinolysis – Reduced breakdown of fibrin deposits contributes to ischemia and tissue necrosis.
Common laboratory findings in LV patients may include:
- Elevated D-dimer – Indicative of hypercoagulability.
- Presence of antiphospholipid antibodies – In some cases, suggesting antiphospholipid syndrome.
- Protein C or S deficiency – Leading to prothrombotic states.
Clinical Features[edit]
Livedoid vasculopathy typically presents with:
- Painful purpuric lesions – Often on the ankles and lower legs.
- Ulcerations with white atrophic scars – Known as atrophie blanche.
- Mottled erythema (livedo racemosa) – Reticulated vascular patterns on the skin.
- Recurrent flares – Periodic exacerbations, often worsened in summer months.
The condition is chronic and relapsing, with ulcer healing leaving stellate white scars that are prone to recurrent breakdown.
Diagnosis[edit]
Diagnosis is based on:
- Clinical presentation – Characteristic purpuric ulcers and atrophie blanche on the lower legs.
- Doppler ultrasound – To assess microvascular blood flow.
- Skin biopsy findings:
- Fibrin thrombi within dermal blood vessels.
- Absence of leukocytoclastic vasculitis.
- Secondary epidermal necrosis.
Differential Diagnosis[edit]
Livedoid vasculopathy should be distinguished from:
- Vasculitis – Inflammatory disorders such as leukocytoclastic vasculitis or polyarteritis nodosa.
- Raynaud’s phenomenon РReversible vasospasm causing cyanosis and ischemia.
- Chronic venous insufficiency – Can cause stasis ulcers but lacks thrombotic features.
- Antiphospholipid syndrome – A hypercoagulable state with thrombotic events.
Treatment and Management[edit]
Since LV is associated with microvascular thrombosis, treatment focuses on anticoagulation and improving circulation.
Pharmacologic Treatment[edit]
- Antiplatelet therapy – Aspirin or clopidogrel to reduce platelet aggregation.
- Anticoagulation – Low-molecular-weight heparin or warfarin in patients with hypercoagulability.
- Fibrinolytic therapy – Pentoxifylline or rivaroxaban to enhance microcirculation.
- Pain management – NSAIDs or topical analgesics.
- Wound care – Prevention of secondary infections.
Lifestyle and Supportive Care[edit]
- Compression therapy – To improve venous circulation.
- Leg elevation – Reduces venous stasis.
- Avoidance of cold exposure – Prevents vasospasm and worsening ischemia.
Prognosis[edit]
Livedoid vasculopathy is a chronic and relapsing condition with periods of remission and exacerbation. Some patients experience spontaneous resolution, while others require long-term anticoagulation to prevent ulcer recurrence.
